Based on the given data, the forecasted values of total sales for analgesic medicines in Canada from 2024 to 2028 show a declining trend:
- 2024: $2.2 billion
- 2025: $2.1 billion
- 2026: $1.9 billion
- 2027: $1.7 billion
- 2028: $1.6 billion
The year-on-year percentage variations are:
- 2025: -4.55%
- 2026: -9.52%
- 2027: -10.53%
- 2028: -5.88%
The Compound Annual Growth Rate (CAGR) over the five-year period from 2024 to 2028 is approximately -7.72%.
Future Trends to Watch
The decline in analgesic medicine sales in Canada suggests a shift in consumer behavior, possibly due to the increased prevalence of alternative treatments or better preventive healthcare. Monitoring the rise of holistic and natural pain management solutions will be crucial in understanding and adapting to this evolving market.
